
[Cancer Research 65, 6820-6827, August 1, 2005]
© 2005 American Association for Cancer Research
Angiopoietin 1 Is Mitogenic for Cultured Endothelial Cells
Shigeru Kanda1,
Yasuyoshi Miyata3,
Yasushi Mochizuki3,
Toshifumi Matsuyama2 and
Hiroshi Kanetake3
Divisions of 1 Endothelial Cell Biology and 2 Cytokine Signaling, Department of Molecular Microbiology and Immunology and 3 Department of Urology, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan
Requests for reprints: Shigeru Kanda, Department of Molecular Microbiology and Immunology, Division of Endothelial Cell Biology, Nagasaki University Graduate School of Biomedical Science, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan. Phone: 81-95-849-7340; Fax: 81-95-849-7343; E-mail: shigeruk{at}net.nagasaki-u.ac.jp.
The angiopoietin (Ang)/Tie2 system is implicated in blood vessel formation and maturation. However, the mitogenic effects of angiopoietins remain to be elucidated. Here, we show that Ang1 is mitogenic for cultured endothelial cells. Ang1 dose-dependently induced the proliferation and increased the labeling index of a murine brain capillary endothelial cell line, IBE cells. Ang1 also increased the labeling index of human umbilical vein endothelial cells (HUVEC). Ang1 up-regulated the expression of cyclin D1 in both of these cells. Ang1 activated mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K) in IBE cells and HUVECs. Activated PI3K was associated with c-Fes protein tyrosine kinase in these cells, but not with Tie2. p70 S6 kinase (p70 S6K) was activated by Ang1-treatment, although this activation was blocked by a PI3K inhibitor, LY294002. Simultaneous treatment of cells with PD98059 (MAPK/extracellular regulated kinase kinase inhibitor) and rapamycin (mTOR inhibitor) completely blocked Ang1-induced mitogenic activity for IBE cells and HUVECs. Although Ang2 at high concentration weakly activated Tie2 and p70 S6K, it failed to activate Ras and MAPK, or to induce cell proliferation. Taken together, these findings indicate that Ang1 exerts mitogenic activity on endothelial cells, which requires activation of both MAPK and p70 S6K.
This article has been cited by other articles:

|
 |

|
 |
 
M. Winderlich, L. Keller, G. Cagna, A. Broermann, O. Kamenyeva, F. Kiefer, U. Deutsch, A. F. Nottebaum, and D. Vestweber
VE-PTP controls blood vessel development by balancing Tie-2 activity
J. Cell Biol.,
May 18, 2009;
185(4):
657 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Tsai and W. M.F. Lee
Tie2 in Tumor Endothelial Signaling and Survival: Implications for Antiangiogenic Therapy
Mol. Cancer Res.,
March 1, 2009;
7(3):
300 - 310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Abdel-Malak, M. Mofarrahi, D. Mayaki, L. M. Khachigian, and S. N.A. Hussain
Early Growth Response-1 Regulates Angiopoietin-1-Induced Endothelial Cell Proliferation, Migration, and Differentiation
Arterioscler Thromb Vasc Biol,
February 1, 2009;
29(2):
209 - 216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zheng, L. P. Christensen, and R. J. Tomanek
Differential effects of cyclic and static stretch on coronary microvascular endothelial cell receptors and vasculogenic/angiogenic responses
Am J Physiol Heart Circ Physiol,
August 1, 2008;
295(2):
H794 - H800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Prince
Hyperoxia and EGFL7: saving cells from too much of a good thing
Am J Physiol Lung Cell Mol Physiol,
January 1, 2008;
294(1):
L15 - L16.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Deng, J. Yang, M. McCarty, and B. Su
MEKK3 is required for endothelium function but is not essential for tumor growth and angiogenesis
Am J Physiol Cell Physiol,
October 1, 2007;
293(4):
C1404 - C1411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Su, N. Zhang, J. He, S. Qu, S. Slusher, R. Bottino, S. Bertera, J. Bromberg, and H. H. Dong
Angiopoietin-1 Production in Islets Improves Islet Engraftment and Protects Islets From Cytokine-Induced Apoptosis
Diabetes,
September 1, 2007;
56(9):
2274 - 2283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S.N. Shim, I. A.W. Ho, and P. E.H. Wong
Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis
Mol. Cancer Res.,
July 1, 2007;
5(7):
655 - 665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Brkovic, M. Pelletier, D. Girard, and M. G. Sirois
Angiopoietin chemotactic activities on neutrophils are regulated by PI-3K activation
J. Leukoc. Biol.,
April 1, 2007;
81(4):
1093 - 1101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kobayashi, L. M. DeBusk, Y. O. Babichev, D. J. Dumont, and P. C. Lin
Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment
Blood,
August 15, 2006;
108(4):
1260 - 1266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P.J. Brindle, P. Saharinen, and K. Alitalo
Signaling and Functions of Angiopoietin-1 in Vascular Protection
Circ. Res.,
April 28, 2006;
98(8):
1014 - 1023.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Association for Cancer Research.